Brief report of efficacy and side effect profile of crossing over to modified-release capsules of methylphenidate in ADHD patients receiving other treatments: case series

OBJECTIVES: Stimulants are recommended as the first-line pharmacotherapy in attention deficit/hyperactivity disorder (ADHD). Methylphenidate (MPH) is the most used stimulant. Medikinet Retard has modified-release capsules of MPH (MRC-MPH). In this study, we aimed to report observations on a sample of...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Burcu Özbaran, Sezen Köse, Fevzi Tuna Ocakoğlu, Hakan Kayış, Ayşegül Satar, Uğur Tekin
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Mesut Çetin 2017-07-01
Цуврал:	Psychiatry and Clinical Psychopharmacology
Нөхцлүүд:	ADHD pharmacotherapy side effects adverse effects psychopharmacology
Онлайн хандалт:	http://dx.doi.org/10.1080/24750573.2017.1358684
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!